Techno Medical Public Company Limited carries a market capitalization of 289.52M, placing it among publicly traded companies globally. Its enterprise value stands at 564.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 289.52M |
| Enterprise Value | 564.66M |
Techno Medical Public Company Limited currently has 308.00M shares outstanding.
| Shares Outstanding | 308.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Techno Medical Public Company Limited trades at a trailing price-to-earnings ratio of 8.43. The price-to-sales ratio is 0.34, and the price-to-book ratio stands at 1.12.
| PE Ratio | 8.43 |
| PS Ratio | 0.34 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | 0.56 |
| P/OCF Ratio | 0.57 |
On an enterprise value basis, Techno Medical Public Company Limited trades at an EV/EBITDA multiple of 6.87 and an EV/FCF ratio of 1.28. The EV/Sales ratio of 0.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.82 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.79 |
| EV / EBITDA | 6.87 |
| EV / EBIT | 11.82 |
| EV / FCF | 1.28 |
Techno Medical Public Company Limited maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 72.08, indicating elevated leverage, while an interest coverage ratio of 6.49 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.48 |
| Quick Ratio | 0.98 |
| Debt / Equity | 72.08 |
| Debt / EBITDA | 4.00 |
| Interest Coverage | 6.49 |
Techno Medical Public Company Limited posts a return on equity of 14.14 and a return on invested capital of 3.91.
| Return on Equity (ROE) | 14.14 |
| Return on Assets (ROA) | 3.14 |
| Return on Invested Capital (ROIC) | 3.91 |
| Return on Capital Employed (ROCE) | 7.17 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.39 |
Over the trailing twelve months, Techno Medical Public Company Limited has paid 12.59M in income taxes, reflecting an effective tax rate of 34.72.
| Income Tax | 12.59M |
| Effective Tax Rate | 34.72 |
Techno Medical Public Company Limited's stock has gained approximately 28.76712% over the past 52 weeks. The 50-day moving average sits at 0.87, while the 200-day moving average is 0.91.
| Beta (5Y) | N/A |
| 52-Week Price Change | 28.76712% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 0.91 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Techno Medical Public Company Limited generated 716.54M in revenue and converted that into 28.85M in net income, yielding earnings per share of 0.08. EBITDA reached 82.25M, while operating income came in at 47.78M.
| Revenue | 716.54M |
| Gross Profit | 259.97M |
| Operating Income | 47.78M |
| Pretax Income | 36.26M |
| Net Income | 28.85M |
| EBITDA | 82.25M |
| EBIT | 47.78M |
| Earnings Per Share (EPS) | 0.08 |
Techno Medical Public Company Limited holds 41.30M in cash and equivalents against 328.91M in total debt, resulting in a net debt position of 276.90M. Total book value stands at 217.98M, with working capital of 171.72M providing operational flexibility.
| Cash & Cash Equivalents | 41.30M |
| Total Debt | 328.91M |
| Net Debt | 276.90M |
| Equity (Book Value) | 217.98M |
| Book Value Per Share | 0.71 |
| Working Capital | 171.72M |
Techno Medical Public Company Limited produced 425.73M in operating cash flow over the past twelve months. After subtracting -7.73M in capital expenditures, free cash flow totaled 418.00M - equivalent to 1.36 per share.
| Operating Cash Flow | 425.73M |
| Capital Expenditures | -7.73M |
| Free Cash Flow | 418.00M |
| FCF Per Share | 1.36 |
Techno Medical Public Company Limited operates with a gross margin of 36.28, reflecting its pricing power and cost economics. The operating margin of 6.67 and net profit margin of 4.03 provide insight into operational efficiency.
| Gross Margin | 36.28 |
| Operating Margin | 6.67 |
| Pretax Margin | 5.06 |
| Profit Margin | 4.03 |
| EBITDA Margin | 11.48 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 174.03 |
| FCF Yield | 178.15 |
Techno Medical Public Company Limited's most recent stock split took place on April 27, 2017 with a 10:11 split ratio.
| Last Split Date | 4/27/2017 |
| Split Ratio | 10:11 |
Techno Medical Public Company Limited posts an Altman Z-Score of 1.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.60 |